NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

The acquisition provides Hybrigenic Services, a subsidiary of Paris-based biopharma firm Hybrigenics that specializes in protein-protein interaction work, with exclusive ownership of patented yeast two-hybrid screening technology for membrane proteins. The deal will expand the company's commercial reach in German-speaking territories, Eastern Europe, and China, it said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.